(Q34185403)

31 July 2017

title

Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles (English)

1 reference

31 July 2017

0 references

1 reference

5

1 reference

31 July 2017

11

1 reference

31 July 2017

2

Ole Ammerpohl

0 references

Ivo Meinhold-Heerlein

10

object named as

Ivo Meinhold-Heerlein

0 references

Norbert Arnold

8

object named as

Norbert Arnold

1 reference

31 July 2017

7

Felix Hilpert

1 reference

31 July 2017

Dirk O Bauerschlag

1

1 reference

31 July 2017

Karen Bräutigam

3

1 reference

31 July 2017

Christian Schem

4

1 reference

31 July 2017

Marion T Weigel

6

1 reference

31 July 2017

Nicolai Maass

9

1 reference

31 July 2017

publication date

16 May 2011

1 reference

31 July 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Oncology

1 reference

31 July 2017

volume

80

1 reference

31 July 2017

issue

1-2

1 reference

31 July 2017

page(s)

12-20

1 reference

31 July 2017

cites work

Cancer statistics, 2010

1 reference

Survival and prognostic factors in patients with ovarian cancer

21 January 2018

1 reference

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

21 January 2018

1 reference

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

21 January 2018

1 reference

Carboplatin alone vs carboplatin plus epidoxorubicin as second-line therapy for cisplatin- or carboplatin-sensitive ovarian cancer.

21 January 2018

1 reference

Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.

21 January 2018

1 reference

The treatment of advanced ovarian carcinoma (I): clinical variables associated with prognosis

21 January 2018

1 reference

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers

21 January 2018

1 reference

DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells

21 January 2018

1 reference

Cross-talk between aging and cancer: the epigenetic language

21 January 2018

1 reference

Epigenetics: regulation through repression

21 January 2018

1 reference

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

21 January 2018

1 reference

DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines

21 January 2018

1 reference

High-definition DNA methylation profiles from breast and ovarian carcinoma cell lines with differing doxorubicin resistance

21 January 2018

1 reference

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

21 January 2018

1 reference

OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer

21 January 2018

1 reference

Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin

21 January 2018

1 reference

Promoter hypermethylation profile of ovarian epithelial neoplasms

21 January 2018

1 reference

Epigenetic regulation of maspin expression in human ovarian carcinoma cells

21 January 2018

1 reference

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

Analysis of strain and regional variation in gene expression in mouse brain

21 January 2018

1 reference

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics

21 January 2018

1 reference

Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer

21 January 2018

1 reference

S100A5: a marker of recurrence in WHO grade I meningiomas

21 January 2018

1 reference

TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer

21 January 2018

1 reference

Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer

21 January 2018

1 reference

TOB suppresses breast cancer tumorigenesis

21 January 2018

1 reference

Multi-ethnic genetic association study of carotid intima-media thickness using a targeted cardiovascular SNP microarray

21 January 2018

1 reference

Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer

21 January 2018

1 reference

Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma

21 January 2018

1 reference

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors

21 January 2018

1 reference

Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer

21 January 2018

1 reference

Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer S

21 January 2018

1 reference

Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.

21 January 2018

1 reference

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

21 January 2018

1 reference

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential

21 January 2018

1 reference

Ovarian cancer: markers of response

21 January 2018

1 reference

Epigenetics in human disease and prospects for epigenetic therapy

21 January 2018

1 reference

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

21 January 2018

1 reference

Molecular detection of prostate cancer: a role for GSTP1 hypermethylation

21 January 2018

1 reference

Prognostic DNA methylation biomarkers in ovarian cancer.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000327746

1 reference

31 July 2017

1 reference